SCHEMBL29698982

SCHEMBL29698982

CC(C)(NC(=O)C1CCCCC1)C(=O)Nc1nc2ccc(OC(F)(F)F)cc2s1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 1/20 0.60
NPC1 O15118 5/20 0.56
RAB9A P51151 5/20 0.56
ALDH1A1 P00352 1/20 0.56
MAOA P21397 1/20 0.53
MAOB P27338 1/20 0.53
MEN1 O00255 1/20 0.53
GFER P55789 1/20 0.53
KMT2A Q03164 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
CLK1 P49759 1/20 0.52
HDAC3 O15379 1/20 0.51
HDAC4 P56524 1/20 0.51
HDAC1 Q13547 1/20 0.51
HDAC7 Q8WUI4 1/20 0.51
HDAC2 Q92769 1/20 0.51
HDAC10 Q969S8 1/20 0.51
HDAC11 Q96DB2 1/20 0.51
HDAC8 Q9BY41 1/20 0.51
HDAC6 Q9UBN7 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30944348 0.89 DYRK1A (0.68) DYRK1ANPC1RAB9AALDH1A1MAOA
SCHEMBL28908448 0.89 DYRK1A (0.68) DYRK1ANPC1RAB9AALDH1A1MAOA
SCHEMBL30944330 0.89 DYRK1A (0.68) DYRK1ANPC1RAB9AALDH1A1MAOA
SCHEMBL28525158 0.89 DYRK1A (0.68) DYRK1ANPC1RAB9AALDH1A1MAOA
Hydrochloric Acid SCHEMBL18154343 0.88 DYRK1A (0.67) DYRK1ANPC1RAB9AALDH1A1MAOA
SCHEMBL28530314 0.88 DYRK1A (0.69) DYRK1ANPC1RAB9AALDH1A1MAOA
SCHEMBL30944386 0.88 DYRK1A (0.69) DYRK1ANPC1RAB9AALDH1A1MAOA
SCHEMBL18154360 0.83 DYRK1A (0.69) DYRK1ANPC1RAB9AMEN1KMT2A
SCHEMBL30795396 0.83 DYRK1A (0.69) DYRK1ANPC1RAB9AMEN1KMT2A
SCHEMBL18154294 0.82 DYRK1A (0.64) DYRK1ANPC1RAB9ASMN1; SMN2HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4011870-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING RILUZOLE PRODRUGS Biohaven Pharmaceutical Holding Company Ltd. (US) 2022-06-15 EP disclosed